Natalia de Albuquerque Rocha, MD

Diabetes medications and cardiovascular outcome trials: Lessons learned

Publish date: October 2, 2017

Drugs of several classes have demonstrated cardiovascular safety; empagliflozin carries a cardiovascular indication.